AzTrials
AzTrials

Chronic PainNCT04297527

Effect of Mulligan Mobilization in Chronic Non-Spesific Low Back Pain

A study testing Conventional Physiotherapy and Mulligan Mobilization in people with Chronic Pain, run by Pamukkale University at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Fifty five participants diagnosed with CNSLBP, will randomized into three groups. Group I (18 subjects) will receive 15 sessions of Conventional Physiotherapy program (CPP) 5 times per week, Group II (19 subjects) will receive 9 sessions of SNAGs, and Group III will receive CPP plus SNAGs. Read more about this study

Who is it for?
Ages 20 to 50 years, women only
Conditions the study is for
Chronic Pain
What is being tested?
Conventional Physiotherapy and Mulligan Mobilization
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
55 participants
Where
1 siteTurkey (Türkiye)
Study dates
14 Jun 2017to Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • low back pain for at least 3 months
  • intensity of pain ranges from 3 to 6 according to VAS

Who cannot join

  • undergoing surgical operation in the lumbar region or having a surgical indication having an exercise therapy and / or physical therapy in the last 1 year
  • a history of trauma involving lumbar region and systemic and inflammatory disease targeting this region
  • corticosteroids consumption for a long time
  • being pregnant.

Trial locations and contacts

1 site in 1 country.

Şule ŞİMŞEK, Dr. contact

+9005058099914

suleserefsimsek@yahoo.com

Merve Bergin Korkmaz, Dr. contact

+905469114635

mbergina@hotmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Denizli State Hospital

    Denizli, 20040

    Merve Bergin Korkmaz, Dr., +905469114635, mbergina@hotmail.com

    Şule Şimşek, Pdh.

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Efficacy of Mulligan Mobilization Technique in Chronic Non-Spesific Low Back Pain

Fifty five participants diagnosed with CNSLBP, will randomized into three groups. Group I (18 subjects) will receive 15 sessions of Conventional Physiotherapy program (CPP) 5 times per week, Group II (19 subjects) will receive 9 sessions of SNAGs, and Group III will receive CPP plus SNAGs. Outcome measures are pain, ROM, spinal mobility, fear avoidance behaviour and function. Measurements will record before, after and 6 month after the end of the treatment.

Read the detailed description

Inclussion criterias are; low back pain for at least 3 months, intensity of pain ranges from 3 to 6 according to VAS. Exclussion criterias are; undergoing surgical operation in the lumbar region or having a surgical indication, having an exercise therapy and / or physical therapy in the last 1 year, a history of trauma involving lumbar region and systemic and inflammatory disease targeting this region, participants using corticosteroids for a long time and being pregnant.Acording to our criterias 55 participants diagnosed with CNSLBP will randomised into three groups. Group 1 will receive Conventional Physiotherapy programme consisting of Hot pack, US and TENS applications. Group II aill receive Lumbar SNAGS consisting of Lumbar Extension SNAGS in prone, SNAGS in lion position and Lumbar flexion SNAGS in sitting, techniques. Group III will receive 9 sessions of SNAGs, and Group III will receive CPP plus SNAGs.Outcome measures are pain, ROM, spinal mobility, fear avoidance behaviour and function. Measurements will record before, after and 6 month after the end of the treatment. All treatment groups were treated with the same researcher. All assessments were made by another blind researcher three times at before, after and 6 month after treatment.

Conditions
Chronic Pain
Being tested
Conventional Physiotherapy, Mulligan Mobilization
Keywords
Lumbal SNAGs, efficiency
Medical subject headings
Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conventional PhysiotherapyProcedure or surgery

    Conventional Physiotherapy consist of Hotpacks, TENS and US.The participants were positioned in prone and supported with a pillow under the abdomen, 20 min hot pack was applied. Therapatic Ultrason were applied with the frequency of 1 MHz, intensity of 1,5 watt/cm² and duration of 5 minute. TENS was applied to the lumbar region with 2-channel, 4 surface electrodes at 60-120 Hz, and 50-100 pulse duration for 20 minutes.

  • Mulligan MobilizationProcedure or surgery

    Also called Lumbal SNAGs

    Extension SNAGS in prone, SNAGS in lion position and Lumbar flexion SNAGS in sitting, techniques were used. The techniques were applied in 3 sets with 10 repetitions and 60 seconds rest between sets.

Study groups in NCT04297527
Study groupRoleWhat they receive
Conventional Physiotherapy GroupExperimentalGroup I (18 subjects) received 15 sessions of Conventional Physiotherapy program (CPP) 5 times per week.
Receives: Procedure: Conventional Physiotherapy
Mulligan Mobilization GroupExperimentalMulligan Mobilization was administered 9 sessions (3 days a week, for 3 weeks). .
Receives: Procedure: Mulligan Mobilization
Conventional Physiotherapy plus Mulligan Mobilization GroupExperimentalConventional Physiotherapy (15 session) plus Mulligan Mobilization Programme (9 session) were applied in this group. CP were applied 5 days a week and CP+MM 3 days a week for 3 weeks.
Receives: Procedure: Conventional Physiotherapy; Procedure: Mulligan Mobilization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of Range of Motion from baseline at 3 weeks and from baseline at 6 months

    ROM is measured by BROM II device during flexion and extension activity.

    Measured: Baseline, 3 weeks,6 months

  2. Change of Spinal Mobility from baseline at 3 weeks and from baseline at 6 months

    Spinal mobility measured by Schober test.

    Measured: Baseline, 3 weeks,6 months

  3. Change from Pain Intensity from baseline at 3 weeks and from baseline at 6 months

    Pain intensity during flexion and extension activity in lumbar region is measured by Numeric pain scale in which "0" shows No pain while "10" shows worst pain.

    Measured: Baseline, 3 weeks,6 months

Secondary outcomes (2)
  1. Change from Fear Avoidance Behaviour from baseline at 3 weeks and from baseline at 6 months

    It ıs measured by Fear Avoidance Behaviour Questionnaire-Turkish.The total score ranges from 0 to 96. Maximum score indicates increased fear avoidanve behaviour

    Measured: Baseline, 3 weeks,6 months

  2. Change from Disability level from baseline at 3 weeks and from baseline at 6 months

    It ıs measured by measured by Rolland Morris Disability Questionnaire-Turkish.Total score ranked from 0 to 24. İncreased score represents disability in functional activities

    Measured: Baseline, 3 weeks,6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Mar 2020
  2. Study start14 Jun 2017
  3. Primary completionJun 2020 (estimated)
  4. Study completionJul 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
55 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04297527
Sponsor's protocol ID
15.11.2016/20
Status last verified
May 2020
First submitted
24 Feb 2020
Last updated
5 May 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Because there is no web site to share my data

Publications

  • Hidalgo B, Pitance L, Hall T, Detrembleur C, Nielens H. Short-term effects of Mulligan mobilization with movement on pain, disability, and kinematic spinal movements in patients with nonspecific low back pain: a randomized placebo-controlled trial. J Manipulative Physiol Ther. 2015 Jul-Aug;38(6):365-74. doi: 10.1016/j.jmpt.2015.06.013. Epub 2015 Jul 26.

    PubMed 26215900
  • Vicenzino B, Paungmali A, Teys P. Mulligan's mobilization-with-movement, positional faults and pain relief: current concepts from a critical review of literature. Man Ther. 2007 May;12(2):98-108. doi: 10.1016/j.math.2006.07.012. Epub 2006 Sep 7.

    PubMed 16959529
  • Hussien HM, Abdel-Raoof NA, Kattabei OM, Ahmed HH. Effect of Mulligan Concept Lumbar SNAG on Chronic Nonspecific Low Back Pain. J Chiropr Med. 2017 Jun;16(2):94-102. doi: 10.1016/j.jcm.2017.01.003. Epub 2017 Mar 30.

    PubMed 28559749

Questions about this trial

What is this clinical trial studying?

A study testing Conventional Physiotherapy and Mulligan Mobilization in people with Chronic Pain, run by Pamukkale University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Şule ŞİMŞEK, Dr. (+9005058099914, suleserefsimsek@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of Range of Motion from baseline at 3 weeks and from baseline at 6 months (time frame: Baseline, 3 weeks,6 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04297527, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 May 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in